Six practitioner-grade documents to structure your response, satisfy your corrective action commitments, and close the Warning Letter correctly.
FDA posts Warning Letters on FDA.gov within days of issuance. Your customers, competitors, and investors can read it. Your 15-business-day response window starts immediately. Most manufacturers waste the first week trying to figure out the format and what FDA actually expects.
This toolkit gives your team a structured protocol for the first 48 hours, an RCA format FDA reviewers recognize, and a CAPA closure evidence standard that satisfies district office expectations — the documentation gap that keeps Warning Letters open long after the underlying problem is fixed.
From triage through closure — in sequence.
Hour-by-hour action plan for the first 48 hours after receiving a Warning Letter. Who to notify, what to preserve, how to assess scope, and how to initiate your response protocol without creating additional liability.
Structured RCA template aligned with FDA's expectations for Warning Letter responses. Covers direct cause, contributing factors, systemic root cause, and the evidence standard FDA expects before accepting a CAPA commitment.
FDA-format CAPA template with milestone structure, responsible parties, verification checkpoints, and completion evidence requirements. Built around the FDA CAPA response format reviewers expect.
Formal FDA correspondence template for Warning Letter responses. Correct structure, required acknowledgments, commitment language, and the documentation attachment protocol FDA's district offices expect.
40+ questions FDA investigators typically ask during follow-up inspections after Warning Letters. Organized by the most common cited violations: CAPA adequacy, management oversight, documentation control, and supplier controls.
Structured template for assembling the evidence package that demonstrates your CAPA was effective. Covers the documentation FDA requires before closing a Warning Letter — the step most manufacturers get wrong.
Stripe checkout. Instant download after payment.
“I built these templates from 12 years of running a Class II/III medical device manufacturing operation. Every document reflects what FDA investigators actually ask for — not what consultants think they ask for. We use these exact frameworks at AB Medical.”
Joshua Millage, CEO — AB Medical Technologies
“When you've been through enough FDA inspections, you learn what documentation gaps get flagged and which ones slide. These templates close the gaps that matter. We developed them alongside our own QMS buildout and they've held up under audit.”
Rick, Director of Engineering & Regulatory — AB Medical Technologies
FDA typically expects a response within 15 business days of receiving the Warning Letter, though this is not a statutory deadline. Your response should commit to a corrective action timeline, not just acknowledge receipt. The clock starts when the letter is received at your registered address.
The RCA and CAPA templates are directly applicable to FDA 483 responses. The response letter template is Warning Letter specific but the document structure maps to 483 response best practices. Many manufacturers use this kit for both.
These are practitioner reference tools, not legal advice. We recommend regulatory counsel review your final response. The templates give your team a structured starting point that meets FDA's formatting and content expectations — which is what typically takes the most time.
Markdown — structured for immediate use with your document control system. Each template includes instructions and examples inline.
Deficient responses extend Warning Letters. A structured response that satisfies FDA's evidence standard closes them.
Stripe checkout. Instant download after payment.